Damage to the retina due to diabetes is now considered the most common cause of blindness in adults. […]

Living long enough to benefit from treatmentBisphosphonates are the main drugs on offer for fracture prevention in osteoporosis. […]

Mathew’s commendable article advocating “major reforms that bring our profession together” not surprisingly falls short of providing details […]

The new development will arm healthcare providers with a vital tool to address the steep rise of malaria […]

The news arrives after the tenth recorded positive Omicron case in Scotland, which the government has confirmed has […]

Bayer pads blockbuster case for Nubeqa with phase 3 win in metastatic prostate cancer fkansteiner Fri, 12/03/2021 – […]

Biogen’s Spinraza, Fosun-Kite’s Yescarta and a controversial Alzheimer’s drug: All you need to know about China’s new state […]

AstraZeneca blocks investor group’s $7.6B buyout of rare disease specialist Sobi: report fkansteiner Fri, 12/03/2021 – 09:18

Fierce Pharma Asia—China’s insulin price cut; Astellas-Dyno gene therapy deal; Fujifilm’s U.K. investment aliu Fri, 12/03/2021 – 10:10

Questions posed by conservative justices of the US Supreme Court during oral arguments on 1 December have indicated […]